Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
- 8 March 2007
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 25 (12), 2173-2179
- https://doi.org/10.1016/j.vaccine.2006.11.055
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Is there an ideal animal model for SARS?Trends in Microbiology, 2006
- Antiviral antibody responses: the two extremes of a wide spectrumNature Reviews Immunology, 2006
- Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian HamstersThe Journal of Infectious Diseases, 2006
- Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly HumansJournal of Virology, 2005
- Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in MiceThe Journal of Infectious Diseases, 2005
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern ChinaScience, 2003
- Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic CorrelatesEmerging Infectious Diseases, 2003
- Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)Thorax, 2003
- Robust Recall and Long-Term Memory T-Cell Responses Induced by Prime-Boost Regimens with Heterologous Live Viral Vectors Expressing Human Immunodeficiency Virus Type 1 Gag and Env ProteinsJournal of Virology, 2002
- High-Level Primary CD8+T-Cell Response to Human Immunodeficiency Virus Type 1 Gag and Env Generated by Vaccination with Recombinant Vesicular Stomatitis VirusesJournal of Virology, 2002